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Aims:  Esophageal-left  atrial  (LA)  ﬁstula  during  atrial  ﬁbrillation  (AF)  ablation  is  a fatal  event.  We  explored
the  relation  of  the  esophagus-to-ablated  point  distance  and  esophageal  temperature  rise.
Methods:  Consecutive  patients  (n  =  106)  underwent  complex  fractionated  atrial  electrogram-guided  AF
ablation  using  CartoMerge;  the  pulmonary  veins  were  isolated  in  23  patients.  Maximum  radiofrequency
(RF)  power  near  the  esophagus  was  15  W.  Ablated  points  with  esophageal  temperature  rise (monitored
with  a probe)  to ≥38.0 ◦C  were  tagged;  if ≥39.0 ◦C,  RF was discontinued.
Results:  Of  1647  ablated  points  near  the  esophagus,  274  were  associated  with  a temperature  rise  to
38.0–38.9 ◦C  and  241  points  to ≥39.0 ◦C. Distances  (mm)  from  points  to esophagus  were  5.1 ±  0.6  (no  rise),
4.2  ±  3.1  (38.0–38.9 ◦C),  2.9  ±  2.5  (≥39.0 ◦C).  Altogether,  15.5%  of  points  in the upper  LA posterior  wall,
41.5%  in the  middle,  and  30.2%  in the  lower  caused  rises  to ≥38.0 ◦C;  8.7%,  24.6%,  and  11.0%  caused  rises  to
≥39.0 ◦C.  The  middle  wall  was  most  affected  (p  <  0.01),  as  shown  by  multiple  logistic  regression  analysis
(both  temperatures).  Points  causing  a rise  increased  signiﬁcantly  as  distance  decreased  (p < 0.001).  The
odds ratio  for  rise  to  ≥38.0 ◦C compared  with  <4.0 to  >5.0  mm  distance  was  2.28  (p  = 0.004).  The  longest
distance  for  ≥38.0 ◦C rise was  18.5  mm.
Conclusion:  Distance  is  an  important  predictor  of esophageal  temperature  rise.  The middle  LA  posterior
wall  is most  vulnerable.  A  dose  of 15  W is  too  high  for ablation,  especially  <4.0  mm  from  the  esophagus.
Points  >20.0  mm  away  are  relatively  safe.
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It has been widely reported that the prevalence of atrial ﬁbrilla-
ion (AF) increases with age and is associated with high mortality
nd morbidity [1–3]. Catheter ablation is an effective approach to
ts management [4–10]. Pulmonary vein isolation (PVI) is one of
he most common strategies for ablation of paroxysmal AF, but
he outcome of PVI alone for patients with persistent AF is poor
11–13]. Additional approaches, such as linear ablation after PVI,
ave also been reported [14–17].  Nademanee et al. described a
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different approach for AF ablation. The strategy involved identi-
fying the target “substrate” sites using electroanatomical mapping
on complex fractionated atrial electrograms (CFAEs) [10,18].  PVI
is not required with this approach, and AF ablation guided solely
by CFAE resulted in a high rate of success in maintaining the sinus
rhythm in patients with paroxysmal or persistent AF. The results
of their study could not be replicated by others [9,19,20], however,
so the role of CFAE-guided ablation in treating AF patients remains
controversial.
It is necessary to consider the complications associated with
catheter ablation of AF. An esophageal-left atrial (LA) ﬁstula is a
rare but fatal complication [21,22]. Cury et al. [23] reported that the
anterior esophagus was in direct contact with the posterior wall of
the LA in all patients, as seen with multidetector computed tomog-
raphy (CT). Esophageal ulcerations have been reported as potential
precursors of an esophageal-LA ﬁstula, and endoscopy has revealed
similar esophageal damage after AF ablation [24–27].  These
vier Ltd. All rights reserved.
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Table 1
Patients’ characteristics.
Mean ± SD
Number 106
Sex (men/women) 88/18
Age (years) 61.3 ± 10.0
BMI  (kg/m2) 24.1 ± 2.8
LAV (ml) 69.0 ± 23.2
LAD (mm) 40.9 ± 6.1
EF  (%) 64.6 ± 11.0
Types of AF (paroxysmal/persistent) 59/47
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cata are presented as mean ± SD or number. BMI, body mass index; LAV, left atrial
olume; LAD, left atrial dimension; EF, ejection fraction; AF, atrial ﬁbrillation.
omplications have been reported to be induced by radiofrequency
RF) delivery at the LA posterior wall, with the esophageal injury
eing caused by conductive heating [21,24–27].
Based on these ﬁndings, AF ablation guided by monitoring the
sophageal temperature and limiting the power and duration of RF
pplication may  reduce the complication risk [24,26]. The reported
ata, however, were based on ablation applied to the pulmonary
ein antrum, so it was not clear if the results could be transposed
o ablated points in all areas of the LA posterior wall. The areas
here CFAE exists are more anterior than posterior, but all of the
osterior wall areas eventually require ablation. The aim of this
tudy was to evaluate the relations between the ablated points on
arts of the LA posterior wall, the distance from the esophagus,
nd the esophageal temperature rise during CFAE-guided ablation
sing the CartoMerge system (Biosense Webster, Diamond Bar, CA,
SA).
ethods
tudy population and protocol
We  studied 106 consecutive patients (59 with paroxysmal AF, 47
ith persistent AF including 13 patients whose AF lasted >1 year).
rom September 2009 to March 2011, we enrolled 18 women  and
8 men  (mean age 61.3 ± 10.0 years) who underwent CFAE-guided
F ablation using CT image integration into an electroanatomi-
al map  with the CARTO mapping system (CartoMerge). PVI was
ombined with CFAE-guided ablation in 23 patients. The patients’
haracteristics are shown in Table 1.
All antiarrhythmia drugs were discontinued at least ﬁve half-
ives before the study, with the exception of amiodarone, which
as discontinued at least 3 months before the study. All patients
rovided written informed consent for the procedure. The study
rotocol was approved by the Institutional Ethics Committee. AF
as deﬁned in accordance with the 2007 Heart Rhythm Society
xpert Consensus Statement [28].
Paroxysmal AF was deﬁned as recurrent AF (two or more
pisodes) that terminates spontaneously within 7 days. Persistent
F was deﬁned as AF that is sustained for more than 7 days or as
F lasting <7 days but necessitating pharmacological or electrical
ardioversion.
omputed tomography imaging
Each patient underwent CT imaging within 1 week prior to
he ablation using a 64-slice CT scanner (Aquillon; Toshiba Med-
cal Systems, Tochigi, Japan). Scanning was performed during a
ingle breath-hold in the craniocaudal direction. A nonionic con-
rast agent (370 mg  I/ml) (Iopamiron 370; Bayer, Osaka, Japan) was
njected via a cubital vein at an infusion rate of 1 ml/kg/s for 15 s.
t was immediately followed by injection of a mixture of nonionic
ontrast and physiological saline at a rate of 0.5 ml/kg/s for 15 s.rdiology 60 (2012) 119–125
Digital Imaging and Communications in Medicine data converted
with a soft tissue algorithm were imported to a CD-ROM to use the
images on the CartoMerge system.
Mapping and ablation
The following AF ablation technique, described by Nademanee
et al. [10,18] was modiﬁed and utilized for this study as reported
before [29,30]. In brief, after the coronary sinus (CS) was cannulated
with a decapolar catheter (Inquiry Luma-Cath; St. Jude Medical,
Irvine, CA, USA) for recording and induction, patients underwent
nonﬂuoroscopic electroanatomical mapping with the CARTO map-
ping system. A 3.5-mm NaviStar ThermoCool catheter (Biosense
Webster) was  used for mapping and ablation in all patients. Heparin
(3000 IU initial bolus, 1000–2000 IU subsequent boluses, as needed
to keep the activated clotting time at >250 s) was administered for
anticoagulation.
All electroanatomical maps were created for patients who were
in AF that was occurring spontaneously or by induction. Burst pac-
ing utilizing a CS catheter to a lower limit of 1:1 capture or up
to 150 ms  was used to induce AF occasionally with an infusion of
isoproterenol (0.01–0.02 g/kg/min). When AF terminated during
the ablation procedure in paroxysmal AF patients, it was reinduced
until it was no longer inducible.
Electroanatomical maps were created and displayed as a short-
est complex interval map. The areas of CFAE were identiﬁed
manually, tagged, and associated with the atrial anatomy created by
CARTO. This enabled the operator to associate areas of CFAE with
the LA, CS, and occasionally the right atrium, thereby identifying
target sites for ablation.
Bipolar recordings were ﬁltered at 30–500 Hz, and the CFAE
was deﬁned as follows: (1) fractionated electrograms with two or
more deﬂections and/or perturbation of the baseline with contin-
uous deﬂection of a prolonged activation complex; and (2) atrial
electrograms with a very short cycle length (≤120 ms).
After acquiring the shortest complex interval maps associated
with CFAE, we  searched the areas of CFAE that had the tagged points
because CFAE areas have temporal spatial stability. RF applications
using a 3.5-mm NaviStar ThermoCool catheter were delivered with
the following conditions: maximum temperature 43.0 ◦C; 15 W of
energy delivered to the posterior wall, which was supposed to be
close to the esophagus, 15 W to the CS, 35 W to all other locations;
irrigation ﬂow rate 17–30 ml/min; RF time ≤40 s at each point.
The primary endpoints during RF ablation were either com-
plete elimination of areas of CFAE or conversion of AF to sinus
rhythm (SR) with or without an intravenous injection of nifekalant
(0.3 mg/kg over 10 min, once or at most twice). Nifekalant is a class
III antiarrhythmia drug similar to ibutilide, which is not available in
Japan. If the arrhythmias were not successfully terminated, internal
cardioversion was performed.
PVI was performed to encircle the left- and right-side PVs in
pairs 1–2 cm from their ostia, as deﬁned by ﬂuoroscopy and a three-
dimensional map  [31]. At the anterior aspect of the left PV, ablation
was performed along the ridge between the left atrial appendage
and the PV ostia.
Pulmonary vein potentials were recorded using a circular
catheter (Inquiry Optima; St. Jude Medical) before and after abla-
tion to conﬁrm the success of PVI. The electrograms were collected
and measured with the Prucka (GE Medical Systems, Milwaukee,
WI,  USA) and CARTO mapping system.
Three-dimensional mapping with CT integrationThe CT images were imported into the CARTO mapping system
using custom-designed software (CartoMerge). It was  used to sep-
arate the LA and PVs from the surrounding cardiac structures when
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Fig. 1. Calculating the distance from ablated points to the esophagus using computed tomography (CT) images. First, registration of the CT images was performed using
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dandmark and surface mapping. Second, the CT images were deleted except for an eso
mage,  and then the registration was “undone.” Finally, the distances from all of the
iew.  LA, left atrium; Eso, esophagus.
sing proprietary software tools. The LA image including the PVs
as merged with real-time electroanatomical maps for registra-
ion. Registration of the CT images was performed using landmark
nd surface mapping.
onitoring esophageal temperature
Esophageal temperature was monitored using a 7 French
sophageal temperature probe (Esotherm; FIAB SpA, Florence,
taly). The probe has ﬁve electrodes, the middle three of which
onitored the esophageal temperature. A temperature probe was
nserted nasally and with ﬂuoroscopic guidance was advanced
nto the esophagus to a position close to the LA. The position
f the temperature probe was adjusted (referring to the ﬂuoro-
copic images) as close as possible to the RF ablation catheter
ip each time an RF application was delivered to the LA poste-
ior wall close to the esophagus. The esophageal temperature was
onitored continuously in real time throughout the procedure
26].
istance from ablated points to esophagus
The ablated points near the esophagus were deﬁned as pos-
erior ablated points that overlapped with the esophagus CT
rom the PA view. The distance from the ablated points to the
sophagus was calculated using the method that evaluates the
iscrepancy of the CT image and the real-time mapping imageeal image. Third, all of the ablated points were registered in regard to the esophageal
d points to the esophagus were measured automatically by the Registration Match
(registration matched view). The minimum distance from all of
the ablated points to the esophagus CT were measured automati-
cally (Fig. 1). The points where the ablation caused the esophageal
temperature rise to 38.0–38.9 ◦C were assigned brown tags. When
the esophageal temperature rose to ≥39.0 ◦C, the RF applica-
tions were discontinued and the points were assigned black tags
(Fig. 2).
Statistical analysis
Data are presented as the mean ± SD. Categorical data were eval-
uated using the 2 test. The two-sample t-test, Mann–Whitney
tests, and analysis of variance were used to compare propor-
tions among groups. A multiple logistic regression model was
used to assess the relative odds of each temperature rise fac-
tor. The results were compared with the distance >5.0 mm from
the ablated points to the esophageal images. p < 0.05 indicated
a signiﬁcant difference. All statistical analyses were conducted
with SPSS software (version 11.5 for Windows; SPSS Japan, Tokyo,
Japan).
ResultsIncidence of AF termination during CFAE-guided ablation
The AF was  converted to SR in 59 (100%) patients with parox-
ysmal AF [30 (51%) with nifekalant] and in 39 (83%) patients
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Fig. 2. Computed tomography images of the left atrium (LA) and pulmonary veins
merged with real-time electroanatomical maps by surface registration. Posteroan-
terior view (a) and inner view (b) of the merged image of the LA and the esophagus.
The  LA was divided into three areas based on the boundary of the left inferior pul-
monary vein (LIPV). Ablated points were measured at the shortest distance from
the esophagus and are shown by three colors: green 0–4.9 mm,  yellow 5.0–9.9 mm,
red ≥10.0 mm.  LAA, left atrial appendage; Eso, esophagus. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web  version of
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Fig. 3. Frequency of the temperature rise in each area of the left atrial posterior
wall. Black bars = number of no-temperature-rise points; dotted bars = number with
a  temperature rise to 38.0–38.9 ◦C; white bars = temperature rise to ≥39.0 ◦C; line
◦ ◦
for 639 ablated points; rise to 38.0–38.9 C for 176 points; rise to
◦his  article.)
ith persistent AF [29 (74%) with nifekalant]. When the AF was
organized” or changed to atrial tachycardia or ﬂutter, we  ablated
he points that showed more organized fractionated potential to
onvert to SR. The points were usually found in areas previously
blated. We  did not perform linear ablation in this study, except
VI. The remaining patients required cardioversion to maintain the
R.
The common areas of the CFAE were at the anterior aspect of
he right PV antrums, the posterior aspect of the left PV antrums,
he ridge of the LA appendage, the proximal CS, and the posterior
eptum of the right atrium. The mean RF time, procedure time, and
uoroscopic time are shown in Table 2.graphs = percentage of temperature rise points for a rise to ≥38.0 C and to ≥39.0 C.
*Signiﬁcantly higher compared with other parts of the left atrial posterior wall
(p  < 0.01).
Differences between SR and AF in the CT images
All of the real-time electroanatomical maps were created dur-
ing AF, either spontaneous or induced during the procedure. In all,
50 paroxysmal AF and 19 persistent AF patients during CT scan-
ning had SR. A total of 12 patients with persistent AF underwent
cardioversion until CT showed that the SR was maintained. Differ-
ences in the accuracy of the CT images compared with the real-time
CARTO map  for SR and AF are shown in Table 3.
Relation between the distance from ablated points to the
esophagus and the temperature rise
We  excluded 5 of the 106 patients for two  reasons: RF applica-
tions caused a temperature rise in the CS (n = 1); and the esophageal
location was obviously different between the CT and ﬂuoroscopic
images (n = 4).
There were 1647 ablated points that were judged close to the
esophagus in 101 patients. We  divided the ablated points according
to their location on the LA posterior wall and the maximum tem-
perature of the esophagus. The LA posterior wall was  classiﬁed into
three parts: upper, middle, lower. The middle part was  deﬁned as
the area from the bottom of the left superior PV to the bottom of the
left inferior PV. There were 252 ablated points in the upper part (no
temperature rise for 213 ablated points; rise to 38.0–38.9 ◦C for 17
points; rise to ≥39.0 ◦C for 22 points). There were 479 ablated points
in the middle part (no temperature rise for 280 ablated points; rise
to 38.0–38.9 ◦C for 81 points; rise to ≥39.0 ◦C for 118 points). There
were 916 ablated points in the lower part (no temperature rise
◦≥39.0 C for 101 points) (Fig. 3). The percentages of ablated points
for which a temperature rise to ≥38.0 ◦C occurred were 15.5% in
the upper, 41.5% in the middle, and 30.2% in the lower posterior
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Table  2
Comparison of various parameters of ablation procedures.
Total CFAE PVI + CFAE23 p value
Number 106 83 23
Radio-frequency time (min) 89.1 ± 28.1 88.8 ± 28.5 90.2 ± 27.1 0.832
Fluoroscopic time (min) 22.8 ± 12.3 19.2 ± 10.5 35.8 ± 8.9 <0.001*
Procedure duration (min) 223.8 ± 47.1 218.8 ± 46.2 242.0 ± 46.9 0.035*
Data are presented as mean ± SD. min, minutes; CFAE, complex fractionated atrial electrogram; PVI, pulmonary veins isolation.
* p < 0.05 vs solely guided by CFAE group.
Table 3
Differences on CT images: sinus rhythm versus atrial ﬁbrillation.
Total CT in sinus rhythm CT in atrial ﬁbrillation p value
Number 106 69 34
CT  and ablation
Procedure interval (days) 2.2 ± 1.4 2.3 ± 1.4 2.0 ± 1.5 0.185
Total  surface points 102 ± 22 103 ± 24 99 ± 16 0.290
Surface registration
Average (mm)  2.1 ± 0.4 2.0 ± 0.4 2.2 ± 0.4 0.005*
Standard deviation (mm) 1.6 ± 0.3 1.5 ± 0.3 1.7 ± 0.3 0.003*
Minimum (mm) 0.038 ± 0.041 0.038 ± 0.041 0.036 ± 0.041 0.752
Maximum (mm)  8.3 ± 2.5 7.9 ± 2.4 9.1 ± 2.5 0.009*
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* p < 0.01 vs CT in AF group.
A; the corresponding percentages for a rise to ≥39.0 ◦C were 8.7%,
4.6%, and 11.0%, respectively. The percentage of ablated points
hat caused a rise to ≥38.0 ◦C was signiﬁcantly higher in the middle
ortion of the LA posterior wall than in the other parts; this was
rue for both temperature parameters—38.0–38.9 ◦C and ≥39.0 ◦C
p < 0.01).
Next, we measured the minimum distance from the esopha-
us to all the ablated points. The distance from the esophagus to
ach part of the LA posterior wall, according to the temperature
ise caused by the ablation is shown. The longest distance from the
blated point causing a rise to ≥38.0 ◦C was 18.5 mm in the lower
osterior LA. The average distance from the esophagus to all the
F-treated points was 4.8 ± 4.0 mm in the upper, 4.3 ± 3.3 mm  in
he middle, and 4.6 ± 3.2 mm in the lower parts.
The distance from the esophagus to the middle part of the LA
osterior wall was signiﬁcantly shorter for a temperature rise to
39.0 ◦C (2.9 ± 2.2 mm)  than for no temperature rise (4.9 ± 3.7 mm)
p < 0.01). The distance from the esophagus to the lower part of the
A posterior wall was signiﬁcantly shorter for a rise to 38.0–38.9 ◦C
4.1 ± 3.1 mm)  and to ≥39.0 ◦C (2.8 ± 2.5 mm)  than for no tem-
erature rise (5.1 ± 3.3 mm)  (p < 0.01). There were no signiﬁcant
ifferences between the ablated points that caused an esophageal
emperature rise and those that caused no temperature rise in the
pper part of the LA posterior wall (data not shown).
ultiple analysis
In age-, sex-, and body mass index (BMI)-adjusted models, mul-
iple logistic regression analysis demonstrated that the distance
rom the esophagus signiﬁcantly correlated with the esophageal
emperature rise caused by RF applications to the LA posterior
all. The upper part of the LA posterior wall had a signiﬁcantly
ower probability of esophageal temperature rise than its other
arts—for ≥38.0 ◦C, the odds ratio (OR) = 0.36, 95% conﬁdence
nterval (CI) = 0.22–0.57, p < 0.001; for ≥39.0 ◦C, the OR = 0.51, 95%
I = 0.28–0.93, p = 0.027. The middle part of the LA posterior wall
ad a signiﬁcantly higher probability of esophageal temperature
ise than other parts of the LA posterior wall—for ≥38.0 ◦C, the
R = 1.66, 95% CI = 1.21–2.27, p = 0.002; for ≥39.0 ◦C, the OR = 2.24,
5% CI = 1.51–3.33, p < 0.001.T. CT, computed tomography; SR, sinus rhythm; AF, atrial ﬁbrillation.
The OR for rise to ≥38.0 ◦C compared with <4.0 to >5.0 mm
distance was  2.28 (p = 0.004). The esophageal temperature rise
was signiﬁcantly increased as the distance from the esophagus
decreased (p < 0.001).
Discussion
This study is the ﬁrst to evaluate the relation between the dis-
tance from ablated points to the esophagus and the esophageal
temperature rise during CFAE-guided AF ablation. The ﬁndings
from this study are as follows.
First, the distance from the esophagus to the ablated points
was the most important predictor of an esophageal temperature
rise during CFAE-guided ablation of the LA posterior wall. The
distance was  5.1 ± 3.6 mm  when there was no temperature rise,
4.2 ± 3.1 mm for a rise to 38.0–38.9 ◦C, and 2.9 ± 2.5 mm  for a rise
to ≥39 ◦C; i.e. the shorter the distance, the greater is the rise.
Second, of the three LA posterior wall portions, the middle one
had the highest possibility of esophageal temperature rise. This
ﬁnding was supported by a multiple logistic regression analysis,
which showed that the percentage points associated with a tem-
perature rise were greater in the middle part than in other parts
of the LA posterior wall (p < 0.01). The distance between esopha-
gus and left atrial posterior wall in antero-posterior direction was
3.6 ± 3.1 mm in the upper, 2.2 ± 2.2 mm in the middle, 2.5 ± 2.1 mm
in the lower parts, then the middle was the shortest (p < 0.01). The
possible impact of this factor on the difference of thermal effects of
RF energy applications in each portion may  be big.
CFAE-guided AF ablation has been reported to produce good
outcomes in patients with paroxysmal or persistent AF [10,32].
Although the distribution of CFAE areas were more abundant in
the anterior than the posterior part of the LA, the posterior aspect
of the left PV is one of the most common CFAE areas [10,33]; and
all of the LA, except the left atrial appendage, has the possibility
of showing fractionated potentials. PVI is the most common strat-
egy for treating paroxysmal AF, but the outcomes after treating
patients with persistent AF by PVI alone are not guaranteed. Addi-
tional treatment using linear ablation and/or CFAE-guided ablation
have been reported [34,35]. Our data may  contribute data not only
for CFAE-guided ablation but also other AF ablations.
1  of Ca
t
t
t
u
d
S
e
t
a
o
m
t
t
b
m
p
i
p
e
C
i
o
1
e
s
C
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[24 R. Maenosono et al. / Journal
Radiofrequency delivery to the LA posterior wall and the resul-
ant conductive heating caused esophageal injury. This study seems
o support the ﬁndings of Martinek et al. [27], who also found
hat the esophageal-LA distance is a risk factor for esophageal
lceration. Our multivariate analysis clearly showed that a shorter
istance caused the greater temperature rise.
tudy limitations
Our study has several limitations. First, the position of the
sophagus may  not be exactly the same on the day of CT as on
he day of ablation. Second, the distance from the esophagus to
blated points was measured at the closest esophageal lesion based
n CT images, but the position of the esophageal temperature probe
ay  not be the closest to the RF points in the esophagus because
he esophageal temperature probe was adjusted only in the ver-
ical position based on ﬂuoroscopic images. Therefore, it should
e emphasized that at the side edge of esophagus, temperature
onitoring might not detect any excessive temperature rise if tem-
erature monitoring electrode is far away from the ablation point
n the horizontal direction. Third, it is not possible to assess the
resence of an esophageal ulcer because it was not investigated by
ndoscopy.
onclusion
The distance from the esophagus to ablated points is the most
mportant predictor of esophageal temperature rise, and the middle
f the LA posterior wall is the most prevalent location. A dose of
5 W is too high to ablate the points, especially within 4.0 mm of the
sophagus. Points >20.0 mm from esophageal images are relatively
afe.
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